Le Lézard
Classified in: Covid-19 virus

Global Ambulatory Healthcare Services Market (2019 to 2027) - Impact of COVID-19 - ResearchAndMarkets.com


The "Ambulatory Healthcare Services - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis and the looming economic recession, the Ambulatory Healthcare Services market worldwide will grow by a projected US$1.1 Trillion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 4.9%. Ophthalmology, one of the segments analyzed and sized in this study, is forecast to grow at over 5.7% and reach a market size of US$897.9 Billion by the end of the analysis period.

The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.

An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Ophthalmology market will be reset to a new normal which going forward in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 3.8% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$33.4 Billion to the region's size over the next 7 to 8 years. In addition, over US$33 Billion worth of projected demand in the region will come from Rest of the European markets. In Japan, the Ophthalmology segment will reach a market size of US$27.2 Billion by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Ambulatory Healthcare Services market.

Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 8.3% over the next couple of years and add approximately US$308.1 Billion in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Ambulatory Healthcare Services market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others:

AmSurg Corp, Apria Healthcare Group, Inc, DaVita Healthcare Partners, Inc, Fresenius Kabi AG, HCA Healthcare, Intergramed America Inc, Sonic Healthcare Ltd, Surgery Partners

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

Total Companies Profiled: 46

For more information about this report visit https://www.researchandmarkets.com/r/rt3ut4


These press releases may also interest you

at 19:59
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...

at 17:50
The First Bancshares, Inc. ("FBMS" or "the Company") , holding company for The First Bank, (www.thefirstbank.com) reported today financial results for the quarter ended March 31, 2024. Highlights for the Quarter: Net income available to common...

at 17:30
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in thedevelopment oftherapeutics for age-related...

at 17:10
Teradyne, Inc. reported revenue of $600 million for the first quarter of 2024 of which $412 million was in Semiconductor...

at 17:00
Alamos Gold Inc. ("Alamos" or the "Company") today reported its financial results for the quarter ended March 31, 2024. "We delivered another strong start to the year across a number of fronts, following a record performance in 2023. Costs...

at 16:57
Ball Corporation's board of directors (the "Board") today declared a cash dividend of 20 cents per share, payable June 17, 2024, to shareholders of record as of June 3, 2024. In addition, the board also approved the repurchase by the company of up...



News published on and distributed by: